Cargando…

PIM-1 Is Overexpressed at a High Frequency in Circulating Tumor Cells from Metastatic Castration-Resistant Prostate Cancer Patients

PIM-1 is an oncogene involved in cell cycle progression, cell growth, cell survival and therapy resistance, activated in many types of cancer, and is now considered as a very promising target for cancer therapy. We report for the first time that PIM-1 is overexpressed in circulating tumor cells (CTC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Markou, Athina, Tzanikou, Eleni, Strati, Areti, Zavridou, Martha, Mastoraki, Sophia, Bournakis, Evangelos, Lianidou, Evi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281625/ https://www.ncbi.nlm.nih.gov/pubmed/32397108 http://dx.doi.org/10.3390/cancers12051188

Ejemplares similares

Prognostic Significance of Gene Expression and DNA Methylation Markers in Circulating Tumor Cells and Paired Plasma Derived Exosomes in Metastatic Castration Resistant Prostate Cancer
por: Zavridou, Martha, et al.
Publicado: (2021)

Comprehensive liquid biopsy analysis as a tool for the early detection of minimal residual disease in breast cancer
por: Stergiopoulou, Dimitra, et al.
Publicado: (2023)

USP44 Promoter Methylation in Plasma Cell-Free DNA in Prostate Cancer
por: Londra, Dora, et al.
Publicado: (2021)

Direct comparison of size-dependent versus EpCAM-dependent CTC enrichment at the gene expression and DNA methylation level in head and neck squamous cell carcinoma
por: Zavridou, Martha, et al.
Publicado: (2020)

Detection and Molecular Characterization of Circulating Tumour Cells: Challenges for the Clinical Setting
por: Strati, Areti, et al.
Publicado: (2023)

miRNA-21 as a novel therapeutic target in lung cancer
por: Markou, Athina, et al.
Publicado: (2016)

Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR
por: Strati, Areti, et al.
Publicado: (2011)

Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancer
por: Strati, Areti, et al.
Publicado: (2013)

PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study
por: Tzanikou, Eleni, et al.
Publicado: (2019)

Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer
por: Chimonidou, Maria, et al.
Publicado: (2017)

Clinical Significance of PD-L1 Status in Circulating Tumor Cells for Cancer Management during Immunotherapy
por: Strati, Areti, et al.
Publicado: (2023)

ESR1 NAPA Assay: Development and Analytical Validation of a Highly Sensitive and Specific Blood-Based Assay for the Detection of ESR1 Mutations in Liquid Biopsies
por: Stergiopoulou, Dimitra, et al.
Publicado: (2021)

Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients
por: Strati, Areti, et al.
Publicado: (2019)

RNA-Based CTC Analysis Provides Prognostic Information in Metastatic Breast Cancer
por: Strati, Areti, et al.
Publicado: (2021)

Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients
por: Ntzifa, Aliki, et al.
Publicado: (2021)

Evaluation of Monocarboxylate Transporter 4 (MCT4) Expression and Its Prognostic Significance in Circulating Tumor Cells From Patients With Early Stage Non-Small-Cell Lung Cancer
por: Markou, Athina, et al.
Publicado: (2021)

The Effect of Genomic DNA Contamination on the Detection of Circulating Long Non-Coding RNAs: The Paradigm of MALAT1
por: Markou, Athina N., et al.
Publicado: (2021)

KMT2C promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer
por: Mastoraki, Sofia, et al.
Publicado: (2020)

Hypoxia-inducible factor-1α and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients
por: Kallergi, Galatea, et al.
Publicado: (2009)

Prognostic impact of indoleamine 2,3-dioxygenase 1 (IDO1) mRNA expression on circulating tumour cells of patients with head and neck squamous cell carcinoma
por: Economopoulou, Panagiota, et al.
Publicado: (2020)

Evaluation of viral concentration and extraction methods for SARS-CoV-2 recovery from wastewater using droplet digital and quantitative RT-PCR
por: Dimitrakopoulos, Lampros, et al.
Publicado: (2022)

HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study
por: Economopoulou, Panagiota, et al.
Publicado: (2019)

Diagnosis and Assessment of Microbial Infections with Host and Microbial MicroRNA Profiles
por: Cui, Lunbiao, et al.
Publicado: (2018)

What's new on circulating tumor cells? A meeting report
por: Lianidou, Evi S, et al.
Publicado: (2010)

Overexpression of Pim-1 in bladder cancer
por: Guo, Shengjie, et al.
Publicado: (2010)

Advances in circulating tumor cells (ACTC): from basic research to clinical practice
por: Lianidou, Evi S, et al.
Publicado: (2013)

Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients
por: Kuske, Andra, et al.
Publicado: (2016)

Detection of ESR1 Mutations in Primary Tumors and Plasma Cell-Free DNA in High-Grade Serous Ovarian Carcinoma Patients
por: Stergiopoulou, Dimitra, et al.
Publicado: (2022)

Detection and relevance of epigenetic markers on ctDNA: recent advances and future outlook
por: Lianidou, Evi
Publicado: (2021)

Potentially inappropriate medications (PIMs): frequency and extent of GP-related variation in PIMs: a register-based cohort study
por: Ribe, Anette Riisgaard, et al.
Publicado: (2021)

RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA
por: Giannopoulou, Lydia, et al.
Publicado: (2017)

Generation of Non-Small Cell Lung Cancer Patient-Derived Xenografts to Study Intratumor Heterogeneity
por: Kanaki, Zoi, et al.
Publicado: (2021)

PD-L1/pS6 in Circulating Tumor Cells (CTCs) during Osimertinib Treatment in Patients with Non-Small Cell Lung Cancer (NSCLC)
por: Pantazaka, Evangelia, et al.
Publicado: (2022)

Circulating miRNAs as Tumor Biomarkers: A Preface to the Special Issue
por: Markou, Athina N.
Publicado: (2020)

Linac4 PIMS
por: Pantelia, Anna
Publicado: (2014)

The role of PIM1/PIM2 kinases in tumors of the male reproductive system
por: Jiménez-García, Manuel Pedro, et al.
Publicado: (2016)

Overexpression of microRNA-486 affects the proliferation and chemosensitivity of mesothelioma cell lines by targeting PIM1
por: Pinelli, Silvana, et al.
Publicado: (2021)

Metabolism-Related Gene Expression in Circulating Tumor Cells from Patients with Early Stage Non-Small Cell Lung Cancer
por: Zafeiriadou, A., et al.
Publicado: (2022)

Characterizing Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles in Metastatic Castration-Naive and Castration-Resistant Prostate Cancer Patients
por: Isebia, Khrystany T., et al.
Publicado: (2022)

Submerged goiter proven to be metastatic infiltration of a neuro-endocrine Merkel cell carcinoma
por: Tsoukalas, Nikolaos, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sktlj0h9qb6f1sjebuc3jp02u9